Gainers
- Ocuphire Pharma, Inc. (NASDAQ:OCUP) shares rose 27.8% to $2.67 in pre-market trading. Ocuphire Pharma entered into a global license agreement for development and commercialization of Nyxol Eye Drops for reversal of mydriasis, presbyopia and night vision disturbances.
- NeuroBo Pharmaceuticals, Inc. (NASDAQ:NRBO) rose 25.5% to $2.71 in pre-market trading after dipping 17% on Monday. NeuroBo Pharmaceuticals recently announced pricing of a $30 million underwritten public offering and concurrent private placement.
- Hims & Hers Health, Inc. (NYSE:HIMS) rose 22.1% to $5.64 in pre-market trading after the company reported better-than-expected Q3 results. The company also issued Q4 and FY22 sales guidance above analyst estimates.
- Tenaya Therapeutics, Inc. (NASDAQ:TNYA) shares rose 17.7% to $2.26 in pre-market trading. Canaccord Genuity initiated coverage on Tenaya Therapeutics with a Buy rating and announced a price target of $21.
- uCloudlink Group Inc. (NASDAQ:UCL) rose 17.2% to $1.08 in pre-market trading after gaining over 4% on Monday.
- ContraFect Corporation (NASDAQ:CFRX) rose 15.2% to $0.1797 in pre-market trading after dropping over 5% on Monday.
- Lordstown Motors Corp. (NASDAQ:RIDE) rose 13.5% to $2.10 in pre-market trading after the company announced Foxconn will invest up to $170 million in the company.
- 2U, Inc. (NASDAQ:TWOU) rose 11.6% to $7.10 in pre-market trading after reporting strong Q3 sales. Piper Sandler upgraded 2U from Underweight to Neutral and lowered the price target from $8 to $7.
- TaskUs, Inc. (NASDAQ:TASK) rose 11% to $17.80 in pre-market trading after the company reported better-than-expected Q3 results. The company also issued Q4 and FY22 sales guidance above analyst estimates.
- LivePerson, Inc. (NASDAQ:LPSN) rose 10.7% to $11.21 in pre-market trading after the company reported better-than-expected Q3 EPS and sales results. The company also issued FY22 sales guidance above analyst estimates.
- Lizhi Inc. (NASDAQ:LIZI) shares rose 9.9% to $0.51 in pre-market trading. LIZHI is expected to report Q3 financial results on Wednesday, November 16, 2022.
- SolarEdge Technologies, Inc. (NASDAQ:SEDG) rose 9.5% to $231.50 in pre-market trading after the company reported better-than-expected Q3 sales results and issued Q4 sales guidance with a midpoint above analyst estimates..
- CTI BioPharma Corp. (NASDAQ:CTIC) rose 8.8% to $5.41 in pre-market trading after the company reported better-than-expected Q3 EPS and sales results.
- Cango Inc. (NYSE:CANG) rose 7.2% to $2.69 in pre-market trading. Cango, last month, declared a special cash dividend of $0.50 per share.
- Ocugen, Inc. (NASDAQ:OCGN) rose 5.2% to $1.61 in pre-market trading.
